Single Guide Rnas Design
Single Guide Rnas Design - Related Videos
09:04
Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
0 Views •
Cited by 12 •
2017
We report the protocols for the synthesis and purification of Peptide Nucleic Acid (PNA) oligomers incorporating modified residues. The biochemical and biophysical methods for the characterization of the recognition of RNA duplexes by the modified PNAs are described.
02:30
siRNA - Small Interfering RNAs
0 Views •
2020
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements. In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:39
lncRNA - Long Non-coding RNAs
0 Views •
2020
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:57
piRNA - Piwi-interacting RNAs
0 Views •
2020
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
06:44
Isolation of Small Noncoding RNAs from Human Serum
0 Views •
Cited by 13 •
2014
This protocol describes a method for extracting small RNAs from human serum. We have used this method to isolate microRNAs from cancer serum for use in DNA arrays and also singleplex quantitative PCR. The protocol utilizes phenol and guanidinium thiocyanate reagents with modifications to yield high quality RNA.
FAQs
A nearby protospacer adjacent motif, or PAM, helps determine whether a genomic sequence can be considered for CRISPR-Cas9 targeting. During design, researchers examine the target region for an appropriate PAM before finalizing the programmable sequence. This requirement narrows candidate sites and connects guide selection with the intended genomic location.
Target accessibility and sequence similarity elsewhere in the genome influence the expected quality of a guide. A less accessible target may reduce editing efficiency, while potential off-target matches can reduce specificity. Evaluating both factors helps researchers compare candidate sgRNAs and select designs better suited to precise experiments in cancer models.
The scaffold provides the structural portion that binds Cas9, whereas the programmable region supplies complementarity to the chosen DNA sequence. Effective configuration therefore requires both parts to be present and correctly associated. Separating these roles helps researchers understand why target selection alone is insufficient when constructing an sgRNA for genome editing.
Researchers first identify the genomic sequence relevant to the experiment, then choose a complementary programmable region with a nearby PAM. They next consider target accessibility and inspect possible off-target matches before configuring the sequence with the Cas9-binding scaffold. This selection process is intended to balance editing efficiency with specificity.
In cancer research, guide designs can support experiments that disrupt oncogenes, modify tumor-suppressor pathways, or interrogate the function of other genes. Applying these designs in cancer models allows researchers to test how selected genomic changes affect gene activity and cancer-related biology, providing a basis for functional studies and target evaluation.
Careful design can improve the efficiency and specificity of targeted editing, making experimental results easier to use in functional genomics. The resulting studies may help validate therapeutic targets and examine gene function in cancer models. More precise guide selection also contributes to genome-engineering strategies aimed at controlled investigation of cancer pathways.